MacuSight Selects etrials' Site Intelligence IVR Solutions

MacuSight Inc. has announced it selected etrials’ Trial Intelligence electronic data capture (EDC) and etrials’ Site Intelligence IVR solutions as the central component of its clinical data management process. This will play a key role in helping MacuSight to attain actionable information from its clinical trial data and thereby enhance and accelerating decision-making.

etrials Worldwide (News - Alert) is a provider of eClinical software and services to pharmaceutical, biotechnology, medical device and contract research organizations.

MacuSight officials said that after a formal evaluation of several eClinical vendors, they selected etrials’ Trial Intelligence EDC and IVR solutions for not only their functionality, but also their experienced client teams who would be implementing these systems as an integral component in the MacuSight studies’ data management, enrollment and randomization efforts.

"The quality of data and the ability to complete a thorough data analysis are critical success factors for any clinical study. etrials’ Trial Intelligence EDC solution affords us rapid and accurate data collection, and offers the ability to integrate pertinent IVR data into EDC in real-time," said Joel Naor, M.D., chief medical officer, MacuSight.

 

MacuSight Inc. focuses on developing innovative therapeutics for the treatment of severe ocular diseases and conditions.

 

The company is dedicated to preserving patients' vision by identifying known, highly-potent and broad-acting small molecule drug compounds that may possess efficacy in treating and/or preventing diseases or conditions of the eye.

Naor also said that every opportunity to improve data collection efficiencies moves the company that much closer to bringing these important new ophthalmology therapies to market.

"In these times of serious economic scrutiny, the pressure on companies like MacuSight to produce innovative products in a cost-efficient manner has never been greater,” said M. Denis Connaghan, CEO and president of etrials.

Connaghan said that the company’s eClinical solutions deliver significant time and costs savings with greater access to actionable information.